Expand AMIX Menu
AMIX MENU

AMIX Latest Press Releases

-- December 5, 2024 --

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 Globe Newswire 8:30 AM

-- November 25, 2024 --

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option Globe Newswire 4:00 PM

-- November 22, 2024 --

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering Globe Newswire 9:15 AM

-- November 11, 2024 --

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update Globe Newswire 8:00 AM

-- October 31, 2024 --

Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction Globe Newswire 8:00 AM

-- October 30, 2024 --

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial Globe Newswire 8:30 AM

-- October 28, 2024 --

Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial Globe Newswire 8:00 AM

-- October 25, 2024 --

Autonomix Medical, Inc. to Participate in a Virtual Investor "What This Means" Segment on Wednesday, October 30th Globe Newswire 11:30 AM

-- October 22, 2024 --

Autonomix Announces Reverse Stock Split Globe Newswire 8:30 AM

-- October 8, 2024 --

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC Globe Newswire 8:30 AM

-- September 26, 2024 --

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Globe Newswire 7:30 AM

-- September 20, 2024 --

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum Globe Newswire 8:30 AM

-- September 9, 2024 --

Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients Globe Newswire 7:00 AM

-- August 27, 2024 --

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference Globe Newswire 8:30 AM

-- August 21, 2024 --

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress Globe Newswire 8:30 AM

-- August 13, 2024 --

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones Globe Newswire 8:00 AM

-- August 2, 2024 --

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Globe Newswire 8:30 AM

-- July 24, 2024 --

Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology Globe Newswire 8:00 AM

-- July 22, 2024 --

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series Globe Newswire 9:05 AM

-- July 18, 2024 --

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment Covering Technology License Agreement Globe Newswire 8:30 AM